Skip to content
MS
Single-pathway Pathway metabolite unreviewed

Chylomicron remnant

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving Chylomicron remnant

Every recorded step where this molecule takes part

Showing all 2 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Trifluoroacetate mediated reduction of atherosclerosis in mice.

    Tang W, Black AS, Moench R, Marzban K, Raygoza Garay JA, Zheng JJ, Conway L, Pinto AFM, Parker CG, Saghatelia… · 2026-09-02

    open access unreviewed
  2. 2
  3. 3
  4. 4
  5. 5
    Decoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined Hyperlipidemia.

    Bararu-Bojan I, Vladeanu MC, Iliescu-Halitchi D, Plesoianu CE, Bojan A, Frasinariu OE, Tudor RC, Ciocoiu M, T… · 2026-07-23

    open access unreviewed
  6. 6
    Familial Chylomicronemia Syndrome Due to a Homozygous LPL c.644G>A Variant and Response to Volanesorsen in Colombia: A Case Report.

    Berrocal C, Charria Rodríguez J, Zumaque Carrascal AM, Jimenez Gomez DV, Pérez Lafont EM, Robayo Perez MA, Fe… · 2026-06-22

    open access unreviewed
  7. 7
  8. 8
    Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside.

    Ginsberg HN, Bornfeldt KE. · 2026-06-04

    cited 2× open access unreviewed
  9. 9
  10. 10
    Bempedoic acid within the phase ternary diagram governing biliary cholesterol solubilization and gallstone risk.

    Di Ciaula A, Khalil M, Garruti G, Portincasa P. · 2026-05-12

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.